PCIF1 Antikörper
-
- Target Alle PCIF1 Antikörper anzeigen
- PCIF1 (PDX1 C-terminal Inhibiting Factor 1 (PCIF1))
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PCIF1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human PCIF1.
- Isotyp
- IgG
-
-
- Applikationshinweise
- WB 1:500-1:2000 IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- PCIF1 (PDX1 C-terminal Inhibiting Factor 1 (PCIF1))
- Andere Bezeichnung
- PCIF1 (PCIF1 Produkte)
- Synonyme
- C20orf67 antikoerper, 2310022K11Rik antikoerper, F730014I05Rik antikoerper, PDX1 C-terminal inhibiting factor 1 antikoerper, PCIF1 antikoerper, Pcif1 antikoerper
- Hintergrund
- Cap-specific adenosine methyltransferase that catalyzes formation of N(6),2'-O-dimethyladenosine cap (m6A(m)) by methylating the adenosine at the second transcribed position of capped mRNAs. Recruited to the early elongation complex of RNA polymerase II (RNAPII) via interaction with POLR2A and mediates formation of m6A(m) co-transcriptionally.
- Molekulargewicht
-
Observed_MW: 81 kDa
Calculated_MW: 81 kDa
- Gen-ID
- 63935
- UniProt
- Q9H4Z3
-